Search Results - "Hogenesch, Harm"

Refine Results
  1. 1

    Mechanism of immunopotentiation and safety of aluminum adjuvants by Hogenesch, Harm

    Published in Frontiers in immunology (01-01-2013)
    “…Aluminum-containing adjuvants are widely used in preventive vaccines against infectious diseases and in preparations for allergy immunotherapy. The mechanism…”
    Get full text
    Journal Article
  2. 2

    Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want by HogenEsch, Harm, O’Hagan, Derek T., Fox, Christopher B.

    Published in npj vaccines (10-10-2018)
    “…Aluminum-containing adjuvants have been used for over 90 years to enhance the immune response to vaccines. Recent work has significantly advanced our…”
    Get full text
    Journal Article
  3. 3

    Intestinal colonization with Candida auris and mucosal immune response in mice treated with cefoperazone oral antibiotic by Das, Diprasom, HogenEsch, Harm, Thangamani, Shankar

    Published in Frontiers in immunology (11-04-2023)
    “…, an emerging multi-drug resistant fungal pathogen, causes invasive infections in humans. The factors regulating the colonization of in host niches are not…”
    Get full text
    Journal Article
  4. 4

    Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant by Lu, Fangjia, HogenEsch, Harm

    Published in Vaccine (20-08-2013)
    “…Highlights • The inflammation after intramuscular injection of aluminum adjuvant was examined. • Early infiltration by neutrophils, followed by macrophages,…”
    Get full text
    Journal Article
  5. 5

    Mechanisms of stimulation of the immune response by aluminum adjuvants by HogenEsch, Harm

    Published in Vaccine (31-05-2002)
    “…Aluminum adjuvants are widely used in human and veterinary vaccines. They are appropriate adjuvants for vaccines that confer protection by inducing antibodies…”
    Get full text
    Journal Article
  6. 6

    Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models by HogenEsch, Harm, Nikitin, Alexander Yu

    Published in Journal of controlled release (10-12-2012)
    “…Experiments with cultures of human tumor cell lines, xenografts of human tumors into immunodeficient mice, and mouse models of human cancer are important tools…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8

    Aluminum Adjuvants-'Back to the Future' by Laera, Donatello, HogenEsch, Harm, O'Hagan, Derek T

    Published in Pharmaceutics (01-07-2023)
    “…Aluminum-based adjuvants will continue to be a key component of currently approved and next generation vaccines, including important combination vaccines. The…”
    Get full text
    Journal Article
  9. 9

    Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation by Hem, Stanley L, Hogenesch, Harm

    Published in Expert review of vaccines (01-10-2007)
    “…Aluminum-containing adjuvants are an important component of many vaccines because they safely potentiate the immune response. The structure and properties of…”
    Get more information
    Journal Article
  10. 10

    Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant by Hernandez-Franco, Juan F., Xie, Shaojun, Thimmapuram, Jyothi, Ragland, Darryl, HogenEsch, Harm

    Published in Frontiers in immunology (05-09-2022)
    “…Recent studies have shown that corn-derived cationic α-D-glucan nanoparticles, known as Nano-11, significantly increase the immune response when used as a…”
    Get full text
    Journal Article
  11. 11

    Effect of medium-chain fatty acids on growth, health, and immune response of dairy calves by Klopp, Rebecca N., Hernandez Franco, Juan F., Hogenesch, Harm, Dennis, Tana S., Cowles, Kate E., Boerman, Jacquelyn P.

    Published in Journal of dairy science (01-09-2022)
    “…It is necessary for the dairy industry to reduce calf morbidity and mortality, and the reliance on antibiotics to treat sick calves, to address the growing…”
    Get full text
    Journal Article
  12. 12

    Profiling of epidermal lipids in a mouse model of dermatitis: Identification of potential biomarkers by Franco, Jackeline, Ferreira, Christina, Paschoal Sobreira, Tiago J, Sundberg, John P, HogenEsch, Harm

    Published in PloS one (26-04-2018)
    “…Lipids are important structural and functional components of the skin. Alterations in the lipid composition of the epidermis are associated with inflammation…”
    Get full text
    Journal Article
  13. 13

    Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives by Patil, Veerupaxagouda, Hernandez-Franco, Juan F., HogenEsch, Harm, Renukaradhya, Gourapura J.

    Published in Frontiers in immunology (31-08-2022)
    “…Nanoparticles (NPs) are increasingly used as efficient vaccine antigen-delivery platforms and vaccine adjuvants. Alpha (α)-D-glucans are polysaccharide…”
    Get full text
    Journal Article
  14. 14

    Local and Systemic Changes in Lipid Profile as Potential Biomarkers for Canine Atopic Dermatitis by Franco, Jackeline, Rajwa, Bartek, Gomes, Paulo, HogenEsch, Harm

    Published in Metabolites (30-09-2021)
    “…Lipids play a critical role in the skin as components of the epidermal barrier and as signaling and antimicrobial molecules. Atopic dermatitis in dogs is…”
    Get full text
    Journal Article
  15. 15

    Retinoic acid determines the precise tissue tropism of inflammatory Th17 cells in the intestine by Wang, Chuanwu, Kang, Seung G, HogenEsch, Harm, Love, Paul E, Kim, Chang H

    Published in The Journal of immunology (1950) (15-05-2010)
    “…Th17 cells are major effector T cells in the intestine, but the regulation of their tissue tropism within the gut is poorly understood. We investigated the…”
    Get full text
    Journal Article
  16. 16

    Keratinocyte-specific deletion of SHARPIN induces atopic dermatitis-like inflammation in mice by Sundberg, John P, Pratt, C Herbert, Goodwin, Leslie P, Silva, Kathleen A, Kennedy, Victoria E, Potter, Christopher S, Dunham, Anisa, Sundberg, Beth A, HogenEsch, Harm

    Published in PloS one (20-07-2020)
    “…Spontaneous mutations in the SHANK-associated RH domain interacting protein (Sharpin) resulted in a severe autoinflammatory type of chronic proliferative…”
    Get full text
    Journal Article
  17. 17

    SHARPIN is a key regulator of immune and inflammatory responses by Wang, Zhe, Potter, Christopher S., Sundberg, John P., Hogenesch, Harm

    Published in Journal of cellular and molecular medicine (01-10-2012)
    “…Mice with spontaneous mutations in the Sharpin gene develop chronic proliferative dermatitis that is characterized by eosinophilic inflammation of the skin and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes by Morefield, Garry, Touhey, Graham, Lu, Fangjia, Dunham, Anisa, HogenEsch, Harm

    Published in Vaccine (24-06-2014)
    “…Highlights • We developed a vaccine targeting Group A Strep. • A stabilized formulation of recombinant fusion protein SpeAB was determined. • Interactions…”
    Get full text
    Journal Article
  20. 20

    Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling by Potter, Christopher S, Wang, Zhe, Silva, Kathleen A, Kennedy, Victoria E, Stearns, Timothy M, Burzenski, Lisa, Shultz, Leonard D, Hogenesch, Harm, Sundberg, John P

    Published in PloS one (21-01-2014)
    “…SHARPIN is a key regulator of NFKB and integrin signaling. Mice lacking Sharpin develop a phenotype known as chronic proliferative dermatitis (CPDM), typified…”
    Get full text
    Journal Article